DAM
ICPT

DLD Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

DLD Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 274
2022
Q2 		– Hold
0
– – – 310
2022
Q1 		– Hold
0
– – – 279
2021
Q4 		– Hold
0
– – – 219
2021
Q3 		– Hold
0
– – – 189
2020
Q3 		– Hold
0
– – – 118
2020
Q2 		– Hold
0
– – – 108
2020
Q1 		– Hold
0
– – – 128
2019
Q4 		– Hold
0
– – – 123
2019
Q3 		– Hold
0
– – – 110
2019
Q2 		– Hold
0
– – – 132
2019
Q1 		– Hold
0
– – – 128
2018
Q4 		– Hold
0
– – – 124
2018
Q3 		– Hold
0
– – – 139
2018
Q2 		– Hold
0
– – – 158

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return